Introduction
Both in clinical practice and in the scientific literature human milk is often treated as though its only important properties were the volume in which it is produced and its nutritional composition in terms of fat, carbohydrate and protein content. Milk which has the misfortune to get to babies by some indirect route is frequently insulted by pasteurizing or boiling, treatments which certainly damage the functional properties of many of its constituent proteins and cells. From an immunologist's viewpoint, human milk represents a fascinating blend of biologically active molecules and living cells which challenge one to explore their origin, control and biological importance.
It is not a new observation that milk is important to the immunity of the neonate. In the nineteenth century it was known that pregnant sheep vaccinated against cowpox gave birth to newborn lambs who were immune and that vaccinial immunization of mothers led to immunity in their infants, but it was not clear how or when the immunity was transmitted-across the placenta or via the milk, and whether, if it was related to antibodies in the milk, these were absorbed into the circulation or acted locally in the gut. By the 1920's it had been shown that, in newborn calves, deprivation of colostrum was lethal. Three-quarters of calves which were deprived of colostrum died of septicaemia and a single feed of colostrum was enough to protect them. This finding has been amply confirmed for domestic animals, and there have been many studies of human babies that show beyond doubt that breast-fed infants have a lower attack rate for a wide variety of infective problems (Chandra, 1979) . It seems reasonable to conclude that at least part of this protection is a direct result of the infant receiving immune protective factors in milk and is not simply a result of nutritional factors or the avoidance of contaminated artificial feeds.
Some of the many antimicrobial properties of milk and factors in milk which are candidates to influence microbial growth are listed in Table 1 (McClelland, McGrath & Samson, 1978) .
The antibodies in milk are exciting protective factors to study because they are specific for particular foreign agents and are susceptible to manipulation by immunization, but one should not be obsessed with antibodies to the exclusion of other constituents. For example, lactoferrin, lysozyme and lactoperoxidase are all potent inhibitors of the growth of many bacteria and there are non-antibody virus inhibitors in milk which are little studied but may be biologically important (Butler, 1979) . Milk contains a wide range of antibodies against micro-organisms and foreign proteins. In contrast to serum, in which IgG predominates, the predominant type of antibody in milk is immunoglobulin A (IgA). Furthermore, the IgA in milk is structurally quite different from that in the serum (Tornasi & Grey, 1972 fig. 1 is over-simplified and there is one complication which should be mentioned because it is relevant to the practical problems of immunization to produce a good antibody response in the breast. The gut-associated lymphoid tissues contain a complex population of lymphocytes. These include different populations of T-lymphocytes, some of which are capable of suppressing immune responses and some of which help the generation of antibody production by B-lymphocytes. The relative activation of the suppressor and helper T-lymphocyte population in the Peyer's patches depends to some extent on the type of antigen and the way in which it is given. It is quite possible to feed antigen to an animal and produce a powerful suppression of immune responses which is, at least in part, due to the production of suppressor T-lymphocytes in the gut-associated lymphoid tissues (Elson, Heck & Strober, 1979) .
As an overall concept, it may be helpful to think teleologically of the need for powerful control mechanisms governing the antibody response to antigens in the gut. Since the gut is constantly exposed to the antigens of tens of millions of bacteria and, over the year, kilograms of foreign protein, it is obvious that without some powerful control mechanism the entire metabolism of an animal could become directed to responding immunologically to this constant massive antigenic challenge.
The breast, unlike the gut, does not work to its full capacity all the time, and only turns on its full production mechanisms during lactation. In non-lactating breast secretions, although IgA is present in high concentrations the total amount of IgA produced is small because of the small volume of secretion. In contrast, in established lactation there is a very substantial output of IgA into the milk. There must be an effective mechanism to allow the breast to increase its output of secretory IgA antibody in lactation, either by making more antibodies within the breast itself or by efficiently transporting them from the blood into the milk (Halsey, Johnson & Cebra, 1980  Holmgren, Hanson, Carlsson, Lindblad & Rahimtoola, 1976 ). These differences presumably reflect the different microbial exposure of the two groups. In individual patients, rather than in population studies, the effect of gut infection or colonization with the bacteria can also be shown. For example, Salmonella infection in a pregnant mother leads to the production of specific antibody in the milk when lactation begins (Allardyce et al, 1974) . Similarly, experimental colonization of a mother's intestine with non-pathogenic E. coli, in the last trimester, leads to production of specific IgA antibodies to that organism in the milk (Goldblum et al, 1975 ).
Immunization to produce specific antibodies in milk Looking at these observations and the underlying physiological mechanisms, it is hard to resist the conclusion that nature has equipped the lactating mother with a system for producing in her milk specific IgA antibody directed against micro-organisms which she encounters in her environment and which are therefore likely to pose a threat to the infant. It would therefore be logical to look for ways of immunizing mothers to improve the quality and quantity of protective antibody in the milk, at least in environments where infection is a major hazard to young infants. However, if this approach is to be a practical possibility, it is necessary to find a convenient method of immunization which does not require the mother to undergo intestinal colonization with the micro-organisms, or actual infection; preferably this would involve the use of conventional vaccines.
In animal studies, it is sometimes possible to boost specific secretory IgA antibody production in the milk by conventional parenteral immunization. This approach has been used to increase levels of milk antibody to Cholera in Pakistani women. Lactating women were immunized parenterally with killed Cholera vaccine. After 14 days, there was a marked increase in milk antibody content, all of which was IgA, accompanied by a strong serum antibody response. In contrast, antibody production of Swedish mothers could not be boosted in this way, suggesting that there was a need for 'priming' of the immune system by an earlier exposure to the organism (Hanson et al, 1979 (Hanson et al, 1979) , presumably because the live vaccine in the gut had activated an inhibitory control mechanism. It seems that any efforts to produce protective antibody in milk will require careful study of the type of antigen and the way it is administered before one can be confident of stimulating production of the required milk antibody.
Importance of antibodies in human milk
Despite the attractiveness of the concept that human milk antibodies are important to the human infant, one must ask what evidence supports it. Secretory IgA from milk has unusual properties which, teleologically, seem well adapted to make it an effective protector of the gut (Tornasi & Grey, 1972 (Samson, Mirtle & McClelland, 1979) . In summary, the lactating human breast is a large scale producer of a form of antibody which is particularly adapted to protecting mucosal surfaces. The breast is part of a generalized mucosal-associated lymphoid system which permits immunization of the breast against organisms experienced by the mother as a result of colonization of the intestine and other sites. This secretory antibody-producing system in the breast is conserved thoughout a very wide range of species and therefore appears to be of evolutionary importance. The possibility now exists for manipulating the production of antibodies in breast milk by immunization. Many other constituents of milk are also important in protecting the neonate against infection. These factors, like antibodies, may be damaged by processing milk: if milk must be fed to infants by an indirect route, it should be treated in ways which preserve these fragile but important components (Björksten et al, 1980) .
